UnitedHealth Group (UNH) PT Raised to $493 at Mizuho

UnitedHealth Group (UNH) PT Raised to $512 at BofA Securities

BofA Securities analyst Kevin Fischbeck raised the price target on UnitedHealth Group (NYSE: UNH) to $512.00 (from $475.00) while maintaining a Buy rating.

The analyst comments "UNH beat consensus by 31% and raised guidance by 12% to $19.50-20.00 (+21% y/y). The upside was... More

UnitedHealth Group (UNH) PT Raised to $441 at Barclays

Barclays analyst Andrew Mok raised the price target on UnitedHealth Group (NYSE: UNH) to $441.00 (from $429.00) while maintaining a Overweight rating.... More

UnitedHealth Group (UNH) PT Raised to $441 at Barclays

Barclays analyst Andrew Mok raised the price target on UnitedHealth Group (NYSE: UNH) to $441.00 (from $429.00) while maintaining a Overweight rating.... More

UnitedHealth Group (UNH) PT Raised to $529 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the price target on UnitedHealth Group (NYSE: UNH) to $529.00 (from $468.00) while maintaining a Overweight rating.... More

UnitedHealth Group (UNH) PT Raised to $500 at Oppenheimer

Oppenheimer analyst Michael Wiederhorn raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $420.00) while maintaining a Outperform rating.... More

UnitedHealth Group (UNH) PT Raised to $490 at UBS

(Updated - July 17, 2026 9:31 AM EDT)

UBS analyst AJ Rice raised the price target on UnitedHealth Group (NYSE: UNH) to $490.00 (from $460.00) while maintaining a Buy rating.

The analyst commented, "The majority of the outperformance recorded in Q2 was related to... More

UnitedHealth Group (UNH) PT Raised to $500 at Truist Securities

Truist Securities analyst David MacDonald raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $480.00) while maintaining a Buy rating.... More

UnitedHealth Group (UNH) PT Raised to $478 at RBC Capital

RBC Capital analyst Ben Hendrix raised the price target on UnitedHealth Group (NYSE: UNH) to $478.00 (from $463.00) while maintaining a Outperform rating.... More

UnitedHealth Group (UNH) PT Raised to $500 at KeyBanc

KeyBanc analyst Matthew Gillmor raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $475.00) while maintaining a Overweight rating.... More

Baird Upgrades UnitedHealth Group (UNH) to Neutral

Baird analyst Michael Ha upgraded UnitedHealth Group (NYSE: UNH) from Underperform to Neutral with a price target of $453.00 (from $287.00).

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $418.52 yesterday.

UnitedHealth rallies premarket while chip stocks retreat; TSMC earnings lift A

Investing.com -- U.S. stock index futures were mixed on Thursday as investors weighed lingering Middle East tensions, and focused on corporate earnings and further signs that U.S. inflationary pressures are easing. 

By 08:10 ET, S&P 500 futures edged down 0.3%, Nasdaq 100 futures fell 1%, while Dow Jones futures rose 0.1%.

Semiconductor stocks were under pressure despite another blockbuster quarter from Taiwan Semiconductor Manufacturing Co., whose second-quarter profit surged 77% year-on-year to a record level, comfortably beating Wall Street expectations.

The worlds largest... More

BofA Securities on UnitedHealth Group (UNH): 'Q2/guidance raise even better than bulls expected'

BofA Securities analyst Kevin Fischbeck reiterated a Buy rating and $475.00 price target on UnitedHealth Group (NYSE: UNH).

The analyst comments "UNH reported Q2 EPS of $6.38, 31% above consensus, and raised 2026 EPS by $1.50 from $18.25 (+12% y/y) to $19.50-20.00 (+21% y/y). The upside was... More

UnitedHealth Group (UNH) PT Raised to $477 at Piper Sandler, 'We would be buyers'

Piper Sandler analyst Jessica Tassan raised the price target on UnitedHealth Group (NYSE: UNH) to $477.00 while maintaining a Overweight rating.

The analyst comments "We would be buyers of UNH on continued execution. Huge 2Q26 beats at UHC and Optum Health... More

UnitedHealth shares surge on strong earnings beat and guidance

Investing.com -- UnitedHealth Group (NYSE: UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

The company posted adjusted earnings of $6.38 per share, beating the analyst consensus of $4.85 by $1.53.... More

Stocks expected to have increasing option volume: TSM UNH GE ABT NFLX PLD ABT USB STT CFG AA ATAI

Stocks expected to have increasing option volume: TSM UNH GE ABT NFLX PLD ABT USB STT CFG AA ATAI

UnitedHealth Group (UNH) Tops Q2 EPS by $1.53, Beats on Revenue; Offers FY26 EPS Guidance

UnitedHealth Group (NYSE: UNH) reported Q2 EPS of $6.38, $1.53 better than the analyst estimate of $4.85. Revenue for the quarter came in at $112 billion versus the consensus estimate of $110.76 billion.

GUIDANCE:

UnitedHealth Group sees FY2026 EPS of $19.50-$20.00, versus the consensus of... More

UnitedHealth Q2 earnings preview: profit growth expected amid favorable utilization trends

Investing.com-- UnitedHealth is expected to post a higher second-quarter profit before the market opens on July 16, as improving utilization trends largely offset weaker performances in prescriptions and insights.

UNH is expected to post earnings per share of $4.85 on revenue of $110.76 billion for the three months to June 30, Investing.com data showed. That compares to EPS of $4.08 and revenue of $111.62 billion from a year... More